News
Do anti–apo A-I antibodies link fatty liver disease and CVD?
Anti–apo A-I antibodies appear to be common in patients with NAFLD and may drive both fat deposits and proinflammatory effects in liver cells,...
News
Blood biomarker a ‘promising’ predictor of psychosis relapse
Copeptin has been shown previously to be a predictor of outcomes in somatic diseases.
News
Motor abnormalities in children a harbinger of serious mental illness?
Previous research has typically focused on affect or cognition, rather than on motor signs, despite the fact that motor signs are a “core symptom...
News
Nonpharma approach a potential ‘game changer’ in schizophrenia?
“We hope that this systematic review could help clinicians understand how to make cognitive remediation even more effective and even more...
News
COVID lockdowns linked to PTSD in patients with eating disorders
These findings should be considered when developing interventions for eating disorders, said lead study author Veronica Nisticò.
News
Potential first-in-class schizophrenia drug cuts negative symptoms
The results “provide further confirmation of the effectiveness of SEP-363856 in treating schizophrenia,” said Dr. Kenneth Koblan.
News
Adjunctive MDMA safe, effective for severe PTSD
"The most interesting part of the study is that the Adverse Childhood Experiences scale had no effect," noted Dr. Bessel van der Kolk.
News
New global telepsychiatry guidelines released
“Now is the time to build a user-friendly digital health care system that can better meet the inevitable future challenges,” said Dr. Davor Mucic...
News
Women with PCOS at increased risk for COVID-19
Women with PCOS may fear an increased infection risk "will further compromise timely access to health care and serve to increase the sense of...
News
Increase in thyroid cancer rates points to overscreening
Large but variable increases in rates of papillary thyroid cancer may point to the “diagnostic pressure” of opportunistic high-sensitivity...
News
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...